IO Biotech Inc. (IOBT)

0.89

-0.02 (-2.66%)

At close: Mar 05, 2025, 3:48 PM

0.90

1.07%

After-hours: Mar 05, 2025, 04:53 PM EST

IO Biotech Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-86.08M	-71.46M	-67.88M	-12.04M	-10.74M
Depreciation & Amortization	756K	540K	2K	n/a	n/a
Stock-Based Compensation	8.06M	7.04M	1.79M	64K	131K
Other Working Capital	5.99M	4.12M	-4.18M	623K	790K
Other Non-Cash Items	-331K	-130K	26.22M	1.87M	828K
Deferred Income Tax	n/a	87K	-2K	n/a	n/a
Change in Working Capital	5.86M	4.19M	-776K	148K	893K
Operating Cash Flow	-71.74M	-59.73M	-40.65M	-9.96M	-8.89M
Capital Expenditures	-323K	-690K	-153K	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-323K	-690K	-153K	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-6.4M	n/a	137.84M	5.1M	9.01M
Financial Cash Flow	71.86M	n/a	252.95M	5.1M	9.01M
Net Cash Flow	603K	-68.94M	208.39M	-4.44M	-125K
Free Cash Flow	-72.06M	-60.42M	-40.8M	-9.96M	-8.89M